NCT07391514 2026-02-06
Deep Learning-Based Intraoperative Dual-tracer Video Analysis of Sentinel Lymph Node Mapping for Metastasis Prediction in cN0 Papillary Thyroid Carcinoma
First Affiliated Hospital of Chongqing Medical University
Completed
Clinical Trials
65 trialsNCT06235814 2026-02-05
MAPS
University of California, Los Angeles
Phase NA Completed
NCT05280379 2025-12-09
Trained Immunity in Thyroid Carcinoma and Colon Carcinoma
Radboud University Medical Center
Completed
NCT04462471 2025-09-08
Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT02973997 2025-08-29
Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC)
Academic and Community Cancer Research United
Phase 2 Completed
NCT05752669 2025-08-21
TEMPEST
Istituto Auxologico Italiano
Completed
NCT04197960 2025-08-05
Microwave Ablation and Surgical Resection for Micropapillary Thyroid Carcinoma
Chinese PLA General Hospital
Phase NA Completed
NCT07066644 2025-07-18
Intraoperative Pathologic Evaluation of Central Lymph Nodes in Papillary Thyroid Carcinoma
Seoul National University Hospital
Completed
NCT03037385 2025-05-31
ARROW
Hoffmann-La Roche
Phase 1/2 Completed
NCT04129411 2025-05-20
Treatment of Papillary Thyroid Carcinoma With Radiofrequency Ablation
Mayo Clinic
Phase NA Completed
NCT05410821 2025-04-01
Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Metastatic Radioactive Iodine Refractory Thyroid Cancer
The First Affiliated Hospital of Xiamen University
Phase 1 Completed
NCT00381641 2025-03-28
Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery
National Cancer Institute (NCI)
Phase 2 Completed
NCT05132205 2025-01-30
Radiofrequency Ablation of Papillary Thyroid Microcarcinoma
Johns Hopkins University
Phase NA Completed
NCT04731467 2024-12-27
A Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors
Purple Biotech Ltd.
Phase 1/2 Completed
NCT05263141 2024-12-03
Retro-Auricular Single-Site Endoscopic to Papillary Thyroid Carcinoma
Sun Yat-sen University
Phase NA Completed
NCT05760690 2024-12-03
Safety of Endoscopic Thyroidectomy Via Retro-Auricular Single-Site Approach, Transoral Approach and Transareola
Sun Yat-sen University
Phase NA Completed
NCT02393690 2024-07-26
Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer
Academic and Community Cancer Research United
Phase 2 Completed
NCT06399159 2024-05-22
Prediction of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma Based on Ultrasound and Cytological Images
Nanchong Central Hospital
Completed
NCT03470259 2024-04-16
TARGET
University Medical Center Groningen
Phase 1 Completed
NCT05507775 2024-04-11
DIGUP-TC
Radboud University Medical Center
Phase NA Completed
NCT06325787 2024-03-25
Image-guided Thermal Ablation vs. Lobectomy for Solitary Papillary Thyroid Microcarcinoma
Chinese PLA General Hospital
Phase NA Completed
NCT06068101 2023-10-05
Clinical and Genetic Investigation of the Association Between Primary Aldosteronism and Thyroid Cancer
Instituto do Cancer do Estado de São Paulo
Completed
NCT06051838 2023-09-25
Prognostic Value of Tumor Deposits for Patients With Papillary Thyroid Carcinoma
Nanfang Hospital, Southern Medical University
Completed
NCT01659385 2023-09-06
LL-PTC
University of Nebraska
Completed
NCT05873283 2023-05-24
Papillary Thyroid Cancer and Central Lymp Node Dissection
Başakşehir Çam & Sakura City Hospital
Completed
NCT00470496 2022-07-25
Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer
Roswell Park Cancer Institute
Phase 1 Completed
NCT02418390 2022-06-01
The Efficacy and Safety of Prophylactic Central Lymph Node Dissection in Papillary Thyroid Carcinoma
Seoul National University Hospital
Phase NA Completed
NCT05191927 2022-01-14
A Nomogram Model to Predict Central Lymphnode Metastasis in Thyroid Papillary Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Completed
NCT02178345 2021-12-08
Predictive MRI Metrics for Tumor Aggressiveness in Papillary Thyroid Cancer
Memorial Sloan Kettering Cancer Center
Completed
NCT01208051 2021-07-15
Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer
National Cancer Institute (NCI)
Phase 1/2 Completed
NCT04594720 2020-10-20
Circulating Biomarkers to Identify Thyroid Cancer
Chang Gung Memorial Hospital
Completed
NCT01441154 2020-09-28
Metabolic Effects of Synthetic Thyroid Hormone for Thyroid Cancer Treatment
National Institutes of Health Clinical Center (CC)
Completed
NCT00668811 2020-08-05
IIT Sutent
Medstar Health Research Institute
Phase 2 Completed
NCT04500925 2020-08-05
The Incidence of Postoperative Re-stratification for Recurrence in Well-differentiated Thyroid Cancer - A Single Tertiary Israeli Center Experience
Tel-Aviv Sourasky Medical Center
Completed
NCT02768753 2019-09-27
Comparison Between the Axillary Bilateral-breast Approach (ABBA) and Bilateral Axillo-breast Approach (BABA) for Robotic Thyroidectomy
Jinan Military General Hospital
Phase NA Completed
NCT00104871 2018-12-19
Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy
National Cancer Institute (NCI)
Phase 2 Completed
NCT03623516 2018-08-09
OTCancer
CHU de Reims
Completed
NCT03359668 2017-12-02
CT Detection of Metastatic Lymphadenopathy in Papillary Thyroid Cancer
University Health Network, Toronto
Phase NA Completed
NCT02561533 2017-07-14
Detection of BRAF Mutation on FNAB From Papillary Thyroid Carcinoma
University of Aarhus
Phase NA Completed
NCT02442661 2017-06-12
Clinical Validation of a Predictive Model for the Presence of Cervical Lymph Node Metastasis in Papillary Thyroid Cancer
University of Colorado, Denver
Completed
NCT00026533 2017-06-06
Thalidomide in Treating Patients With Thyroid Cancer
University of Kentucky
Phase 2 Completed
NCT00095836 2017-05-31
Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy
Massachusetts General Hospital
Phase 2 Completed
NCT00519896 2017-04-25
Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer
University of Washington
Phase 2 Completed
NCT01534897 2017-03-15
Re-differentiation of Radioiodine-Refractory BRAF V600E-mutant Papillary Thyroid Carcinoma With GSK2118436
Massachusetts General Hospital
Phase NA Completed
NCT00118248 2017-02-15
Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT02323724 2016-09-22
APPLICATION OF MOLECULAR TECHNIQUES FOR IMPROVING THE DIAGNOSIS AND TREATMENT OF NODULAR THYROID LESIONS.
Corporacion Parc Tauli
Completed
NCT00795782 2016-04-15
Prophylactic Central Lymph Node Dissection in Papillary Thyroid Microcarcinoma
Samsung Medical Center
Phase 3 Completed
NCT01413113 2015-11-05
Iodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer Previously Treated With Iodine I 131 That Cannot Be Removed By Surgery
University of Washington
Phase 1 Completed
NCT00295763 2015-03-18
A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen.
Sanofi
Phase 3 Completed
NCT01311089 2015-01-27
A Comparative Study of Robotic Thyroidectomy Using Transaxillary Approach Versus Conventional Open Thyroidectomy
Yonsei University
Completed